SYNOPSIS Previous work suggested that during the catabolism of haemoglobin a physico-chemical form of iron was released which was more readily chelatable by desferrioxamine than normal storage forms, as ferritin-haemosiderin. Desferrioxamine chelation was therefore investigated in five patients with major fractures in which haemoglobin catabolism is greatly enhanced by the red cell destruction which proceeds in the associated haematoma. Considerable increases in the amounts of iron mobilized by desferrioxamine were observed from the second day after injury. In severe interstitial haemorrhage, these values tended to increase until 10 to 20 days, and sometimes were as high as chelation values seen in haemochromatosis. These results are considered to support the hypothesis that a highly chelatable form of iron is found at some stage during haemoglobin catabolism.
During a study of the iron-chelating agent desferrioxamine, a method of measuring the amount of body iron chelated by a standard intravenous bodyweight dose of desferrioxamine was devised (Fielding, 1965 28 February 1966 in whom it could be assumed that significant haemorrhage had occurred into soft tissues, mostly at a known time. It shows that in the course of haemoglobin degradation, which occurs at the site of the haematoma, considerable amounts of iron become available for chelation by desferrioxamine, in greater quantity than can be accounted for by the local increase in ferritin-haemosiderin.
MATERIALS AND METHODS
Chelation of body iron by desferrioxamine was estimated by the differential ferrioxamine test (Fielding, 1965) . Briefly, the procedure consists of an intravenous injection of a body-weight dose of desferrioxamine methanesulphonate (Desferal, Ciba), together with a bodyweight dose of ferrioxamine labelled with 2 .c. 59Fe. A single six-hour specimen of urine is collected. The total amount of ferrioxamine excreted is estimated chemically (Fielding and Brunstrom, 1964) and the proportion of the intravenous dose of ferrioxamine excreted in six hours is estimated as 59Fe by standard methods. The urinary ferrioxamine is derived partly from the intravenous dose and partly from body iron chelated by desferrioxamine. The amount of body iron chelated (Fv) is calculated as previously described and is expressed as micrograms ferrioxamine per kilogram body weight. It Table) .
TOTAL IRON-BINDING CAPACITY In four of the five patients, low serum iron-binding capacities were also observed, and these low values also tended to persist for periods up to 40 days (see Table) . (1953) showed that serum iron fell after major surgery and remained low for 12 days' observation. These observations were extended to include other forms of stress, including fractures and coronary occlusion (Feldthusen and Lassen, 1954) , when it was shown that serum iron values were normal at four and 12 hours after stress, but were markedly reduced by 24 hours. Nylander (1955) also studied long-bone fractures and found that serum transferrin was reduced as well as serum iron. On the day of injury, T.I.B.C. values were normal, but fell regularly by 24 hours. He suggested that these effects were part of the adrenocortical response to stress, operating throughreticuloendothelial function. Baird and Podmore (1965) also showed that after major surgery serum iron fell within six hours; plasma iron turnover was reduced.
The present findings agree with these previous observations on the effect of injury on serum iron and total iron-binding capacity. The low values were seen to persist for as long as six weeks where surgical intervention was undertaken. It is perhaps not widely known that this phenomenon seriously limits the value of serum iron and T.I.B.C. estimations in the diagnosis of anaemias in surgical patients. They certainly add no weight to the differentiation of the anaemias of iron deficiency, infection, malignancy, or renal failure, and may be misleading.
It has been suggested that transferrin-bound iron is the immediate source of iron chelated by desferrioxamine, since serum iron is usually raised in conditions such as haemochromatosis, which give high chelation values. In support of this, Wohler (1962) showed that transferrin may be deprived of its bound iron by desferrioxamine in vitro, although Ventura (1964) and Hallberg and Hedenberg (1965) brought evidence to show that it does not occur in vivo to any measurable extent. The association of greatly increased body-iron chelation by desferrioxamine in the presence of low serum iron values, in the cases reported here, suggests that transferrinbound iron is not a significant source or an intermediary in the mobilization of body iron by desferrioxamine.
BODY-IRON CHELATION AFTER FRACTURE When measured within 24 hours after a major fracture and therefore after a presumed soft-tissue haemorrhage, the amount of iron mobilized by desferrioxamine was found to be normal in three patients and in the iron-deficiency range in one. From the second day after injury, greatly increased amounts of body iron became available for mobilization by the chelating agent. The amounts of iron mobilized exclude the possibility that this increase derives from normal storage sites. It is reasonable therefore to assume that the site from which this increased mobilization of iron occurs is in the soft-tissue haematoma associated with fractures where rapid degradation of haemoglobin is in process. It is of course obvious that some increase in mobilizable iron would occur at the site, since ferritin and haemosiderin are being formed and thus are adding to the total amount of 'storage iron'. But the quantitative features of the results show that this could make only a minor contribution to the increases observed. If it is assumed that as much as 1 litre of blood is shed at the site of the fracture and all the haemoglobin iron is transformed at one time, this would provide about 500 mg. iron as ferritin-haemosiderin. This is to be compared with the findings in haemochromatosis (Fielding, O'Shaughnessy, and Brunstrom, 1966) in which iron stores, 40 to 80 times as great, give rise to chelation values of about the same order. The increase in ferritin and haemosiderin at the site of the haematoma can therefore account for only a small part of the increase in desferrioxamine-mobilizable iron observed. Since haemoglobin iron itself is not chelatable by desferrioxamine, these results offer additional evidence for the presence ofa readily chelatable form ofiron in the course ofhaemoglobin catabolism.
The variable anatomical disposition, the amounts and timing of interstitial haemorrhage after fractures, and the subsequent intervention of surgery, preclude the possibility of observing an exactly reproducible pattern of chelation values in each case. However, in the group as a whole, it may be seen that mobilizable iron increases towards a maximum between 10 and 20 days and may not return to normal levels until more than 30 days. It is of interest to relate this pattern of varying chelatibility to the events occurring in a haematoma in soft tissue. A classical description of these events was given by Niven (1935) and by Muir and Niven (1935) , who studied red cell phagocytosis in tissue culture and in experimental subcutaneous haematomas in the mouse, rat, and rabbit. Haemolysis of free interstitial red cells seems to play only a minor part in their disposal. Phagocytosis by proliferating histiocytes proceeds at a rapidly increasing rate and is described as remarkable by 48 hours. Phagocytosis continues as long as red cells remain free and at eight days it is as active as at earlier stages. Free haemoglobin is to be seen in the haematoma until the fifteenth day. In individual phagocytes, the amount of prussian blue-reacting iron increases from the first faint diffuse reaction within hours after haematoma formation, until fine and coarse granules of haemosiderin appear. In the haematoma as a whole, the amount of haemosiderin (and of 'haematoidin') gradually increases and 'large amounts' are present when the observations were discontinued at 36 days in the mouse and 43 days in the rat. In relating these events to the amount of iron available for chelation at varying times after injury, it may be seen, first, that chelation values are already above the normal range on the second day, when only a small proportion of total haemoglobin iron in the haematoma could be transformed to haemosiderin; second, that chelation increases to about the time when free haemoglobin may still be recognized in the haematoma; and third, that when chelation decreases, large amounts of haemosiderin are still at the site. These considerations also suggest that ferritinhaemosiderin is not the source of the high chelation activity.
This investigation provides further evidence for the view that during the catabolism of haemoglobin, iron is released from its porphyrin linkage in a physico-chemical form which is highly susceptible to chelation by desferrioxamine. The chelatability may be an expression of its chemical form or of its accessibility by the chelating agent, or both factors may operate.
It was previously suggested (Fielding, 1965 ) that if chelatability with desferrioxamine were paralleled by chelatability with physiological chelators such as transferrin, it becomes possible to understand how iron derived from the constant breakdown of haemoglobin is preferentially utilized for further haem synthesis, to the virtual exclusion of storage iron for this purpose. The coincidence in time of spontaneous recovery from post-traumatic anaemia, with the increasing amounts of desferrioxamine-chelatable iron, is suggestive of a parallelism between transferrin and desferrioxamine chelatibility.
